The emerging treatment of this peptide represents a significant development in the care of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide403939.ageeksblog.com/40376112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment